When hope is all there is left.

摘要

She was an experienced patient, this 54-year-old woman I saw in my outpatient clinic. Thirteen years before, Mrs. B. had been treated with cyclophosphamide, doxorubicin, vin-cristine, and prednisolone (CHOP) because of a non-Hodg-kin lymphoma (NHL) stage IVB, resulting in a complete remission. Now she was diagnosed with multiple pulmonary metastases of a Ewing sarcoma of unknown primary origin. Moreover, a new bone marrow biopsy showed recurrence of the NHL. Although the CT images of thorax were clouded with metastases, she had no complaints, except for a mild cough and grade 1 neuropathy as a result of the previous treatment with CHOP.